374 related articles for article (PubMed ID: 21789890)
1. Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.
Gui ZH; Liu J; Wang Y; Ali U; Wang T; Chen L
Chin J Physiol; 2011 Apr; 54(2):96-104. PubMed ID: 21789890
[TBL] [Abstract][Full Text] [Related]
2. Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons.
Chen L; Zhang QJ; Liu J; Wang S; Ali U; Gui ZH; Wang Y
Brain Res; 2009 Aug; 1286():192-200. PubMed ID: 19545547
[TBL] [Abstract][Full Text] [Related]
3. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.
Zhang QJ; Wang S; Liu J; Ali U; Gui ZH; Wu ZH; Hui YP; Wang Y; Chen L
Brain Res; 2010 Feb; 1312():127-37. PubMed ID: 19948151
[TBL] [Abstract][Full Text] [Related]
4. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Aoi M; Date I; Tomita S; Ohmoto T
Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
[TBL] [Abstract][Full Text] [Related]
6. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wu ZH; Li Q
Brain Res; 2010 Jan; 1310():189-99. PubMed ID: 19896932
[TBL] [Abstract][Full Text] [Related]
7. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Liu H; Jia L; Chen X; Shi L; Xie J
Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
[TBL] [Abstract][Full Text] [Related]
8. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease.
Howells FM; Russell VA; Mabandla MV; Kellaway LA
Behav Brain Res; 2005 Dec; 165(2):210-20. PubMed ID: 16159673
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
[TBL] [Abstract][Full Text] [Related]
10. Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus.
Bouali-Benazzouz R; Tai CH; Chetrit J; Benazzouz A
Neuroscience; 2009 Dec; 164(2):588-96. PubMed ID: 19628021
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of (-)-stepholidine on the firing activity of substantia nigral dopamine neurons after repeated reserpine treatment.
Sun BC; Jin GZ
Biol Signals; 1992; 1(6):331-8. PubMed ID: 1307933
[TBL] [Abstract][Full Text] [Related]
12. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
13. Involvement of astroglial fibroblast growth factor-2 and microglia in the nigral 6-OHDA parkinsonism and a possible role of glucocorticoid hormone on the glial mediated local trophism and wound repair.
Silva C; Fuxe K; Chadi G
J Neural Transm Suppl; 2009; (73):185-202. PubMed ID: 20411778
[TBL] [Abstract][Full Text] [Related]
14. Expression of magnesium transporter SLC41A1 in the striatum of 6-hydroxydopamine-induced parkinsonian rats.
Lin L; Yan M; Wu B; Lin R; Zheng Z
Brain Res Bull; 2018 Sep; 142():338-343. PubMed ID: 30172737
[TBL] [Abstract][Full Text] [Related]
15. The theta-related firing activity of parvalbumin-positive neurons in the medial septum-diagonal band of Broca complex and their response to 5-HT1A receptor stimulation in a rat model of Parkinson's disease.
Li LB; Han LN; Zhang QJ; Sun YN; Wang Y; Feng J; Zhang L; Wang T; Chen L; Liu J
Hippocampus; 2014 Mar; 24(3):326-40. PubMed ID: 24174292
[TBL] [Abstract][Full Text] [Related]
16. The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study.
Minabe Y; Emori K; Toor A; Stutzmann GE; Ashby CR
Synapse; 1996 Jan; 22(1):35-45. PubMed ID: 8822476
[TBL] [Abstract][Full Text] [Related]
17. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
18. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
19. Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.
Grünblatt E; Mandel S; Maor G; Youdim MB
J Neurochem; 2001 Apr; 77(1):146-56. PubMed ID: 11279270
[TBL] [Abstract][Full Text] [Related]
20. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
